Slovak patient faces systemic barriers to accessing non-categorized innovative oncology treatment

A 30-year-old patient in Slovakia is unable to access an innovative brain tumor treatment because the drug is not included in the national categorized list. The case highlights a recurring systemic issue regarding insurance coverage for non-standard medical therapies in the country.